Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

Dyne Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 07, 2026 WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that John Cox, president and chief executive officer, is […]

Arrive AI Celebrates 2025 Milestones

Nasdaq Debut, Healthcare Deployments, Global Expansion, and Accelerating Innovation INDIANAPOLIS, INDIANA / ACCESS Newswire / January 7, 2026 / Arrive AI (NASDAQ:ARAI), the autonomous delivery network company powering secure, AI-driven delivery for healthcare and enterprise, today released its 2025 Year in Review, highlighting major public-market, product, partnership, and intellectual property milestones achieved throughout the year.

Digital Currency X Technology Expands Digital Asset Strategy Through Token Staking with EdgeAI Foundation

(NASDAQ:DCX), NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Digital Currency X Technology Inc. (NASDAQ: DCX) (“DCX” or the “Company”), a digital asset treasury management company specializing in cryptocurrency custody and storage infrastructure, today announced the execution of a staking agreement with EdgeAI Foundation (the “Foundation”) to stake a portion of its EdgeAI token holdings.

Digital Currency X Technology Expands Digital Asset Strategy Through Token Staking with EdgeAI Foundation

Digital Currency X Technology Expands Digital Asset Strategy Through Token Staking with EdgeAI Foundation GlobeNewswire January 07, 2026 NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Digital Currency X Technology Inc. (NASDAQ: DCX) (“DCX” or the “Company”), a digital asset treasury management company specializing in cryptocurrency custody and storage infrastructure, today announced the execution of

Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy

(OtherOTC:GLUC),(OTC US:GLUC), BENTONVILLE, Ark., Jan. 07, 2026 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today confirmed that all members of the Board of Directors holding preferred shares elected to convert their shares, along with all other preferred shareholders, at a shareholder-friendly 85% premium

Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy

Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy GlobeNewswire January 07, 2026 BENTONVILLE, Ark., Jan. 07, 2026 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today confirmed that all members

Scroll to Top